A. Rey

发表

Outcomes After Combined Therapy Including Surgical Resection in Patients with Epithelial Ovarian Cancer Recurrence(s) Exclusively in Lymph Nodes

C. Haie-meder, P. Morice, C. Uzan, 2004, International Journal of Gynecologic Cancer.

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.

C. Haie-meder, F. Bertucci, B. Weber, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case‐control study with radiotherapy alone

C. Haie-meder, P. Morice, P. Kerbrat, 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.

M. Stevens, J. Michalski, A. Ferrari, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

SIOP MMT 95: Intensified (6 drug) versus standard (IVA) chemotherapy for high risk non metastatic rhabdomyosarcoma (RMS).

O. Oberlin, C. Ellershaw, A. Rey, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.

M. Stevens, A. Kelsey, J. Merks, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.

C. Haie-meder, M. Schlumberger, P. Morice, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of heat shock protein 70 and c-myc in cervical carcinoma.

P. Duvillard, A. Rey, H. S. Abd El All, 1998, Anticancer research.

Survival in cervix cancer patients treated with radiotherapy followed by radical surgery.

C. Haie-meder, R. Rouzier, R. de Crevoisier, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Radiotherapy and radical surgery for treatment of patients with bulky stage IB and II cervical carcinoma.

C. Haie-meder, P. Morice, P. Duvillard, 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis.

J. Droz, A. Kramar, M. Klink, 1988, Seminars in surgical oncology.

Colorectal carcinomas: diagnosis and preoperative staging by hydrocolonic sonography.

A. Rey, C. Hernández-Socorro, C. Guerra, 1995, Surgery.

Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study.

D. Elias, P. Morice, C. Pomel, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multimodal Treatment With Doxorubicin, Cisplatin, and Ifosfamide for the Treatment of Advanced or Metastatic Uterine Leiomyosarcoma: A Unicentric Experience

C. Haie-meder, C. Balleyguier, A. Leary, 2015, International Journal of Gynecologic Cancer.

Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma

C. Haie-meder, C. Genestie, P. Morice, 2000, Cancer.

Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.

E. Darai, P. Morice, C. Uzan, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.

E. Darai, P. Morice, C. Uzan, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Risk adapted chemotherapy for localised Ewing's sarcoma of bone: the French EW93 study.

B. Bui, O. Oberlin, J. Michon, 2012, European journal of cancer.

Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology.

C. Haie-meder, M. Stevens, M. Terrier-Lacombe, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infantile fibrosarcoma: management based on the European experience.

A. Ferrari, M. Carli, D. Orbach, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infantile Fibrosarcoma: Management Based on the

A. Ferrari, M. Carli, D. Orbach, 2010 .

Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging.

C. Haie-meder, P. Morice, C. Uzan, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Para-Aortic Involvement and Interest of Para-Aortic Lymphadenectomy after Chemoradiation Therapy in Patients with Stage IB2 and II Cervical Carcinoma Radiologically Confined to the Pelvic Cavity

C. Haie-meder, P. Morice, C. Uzan, 2007, Annals of Surgical Oncology.

Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases.

C. Haie-meder, S. Culine, P. Morice, 2011, European journal of cancer.

Lymphatic Spread in Stage Ib and II Cervical Carcinoma: Anatomy and Surgical Implications

P. Morice, P. Duvillard, D. Castaigne, 1998, Obstetrics and gynecology.

Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy

C. Haie-meder, C. Balleyguier, P. Morice, 2008, Cancer.

First results of a randomized trial on immunotherapy of head and neck tumors.

F. Eschwège, J. Droz, H. Sancho-garnier, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Epidemiological features of Wilms' tumor: results of studies by the International Society of Paediatric Oncology (SIOP).

P. Voûte, M. Carli, G. Pastore, 1988, Medical and pediatric oncology.

Prognostic factors in advanced nonseminomatous testicular cancer a multivariate logistic regression analysis

C. Théodore, J. Droz, J. Caillaud, 1988, Cancer.

Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: Combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumor

James R. Anderson, F. Ullrich, M. Stevens, 2011, International journal of cancer.

Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type.

F. Mayer, P. Morice, P. Kerbrat, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience.

J. Droz, M. Spielmann, P. Fargeot, 1991, European journal of cancer.

Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy.

D. Atallah, P. Morice, P. Duvillard, 2004, European journal of gynaecological oncology.

Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.

P. Morice, P. Duvillard, G. Dubernard, 2005, Gynecologic oncology.

Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.

P. Morice, C. Pomel, P. Duvillard, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease.

P. Morice, C. Uzan, S. Gouy, 2009, European journal of obstetrics, gynecology, and reproductive biology.

A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.

J. Droz, A. Kramar, J. Pico, 1992, Bulletin du cancer.

Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination.

C. Haie-meder, P. Morice, D. Castaigne, 2000, Fertility and sterility.

Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysis.

C. Haie-meder, D. Atallah, P. Morice, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy.

C. Haie-meder, D. Atallah, P. Morice, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients.

C. Haie-meder, C. Genestie, D. Atallah, 2003, European journal of gynaecological oncology.

Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.

C. Haie-meder, P. Morice, C. Uzan, 2011, The oncologist.

Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.

P. Morice, C. Uzan, S. Gouy, 2009, The oncologist.

Relations between arthralgia and fear of recurrence: results of a cross-sectional study of breast cancer patients treated with adjuvant aromatase inhibitors therapy

S. Dauchy, C. Charles, M. Spielmann, 2015, Supportive Care in Cancer.

Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop.

James R. Anderson, F. Ullrich, M. Stevens, 2006, The Journal of urology.

Histopathological classification of childhood rhabdomyosarcoma: a report from the International Society of Pediatric Oncology pathology panel.

H. B. Marsden, J. Caillaud, C. Rodary, 1989, Medical and pediatric oncology.

Treatment of intracranial ependymomas of children: review of a 15-year experience.

J. Habrand, M. Terrier-Lacombe, D. Sarrazin, 1994, International journal of radiation oncology, biology, physics.

Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6.

L. Simonato, S. Guzzinati, M. Carli, 1997, Medical and pediatric oncology.

Extensive cytoreductive surgery in advanced ovarian carcinoma.

P. Duvillard, P. De Iaco, M. el-Hassan, 1997, European journal of gynaecological oncology.

Treatment of malignant gliomas with surgery, intra-arterial infusions of 1-(2-hydroxyethyl)chloroethylnitrosourea, and radiation therapy: a phase II study.

G. Chatellier, J. Chiras, D. Fohanno, 1990, Neurosurgery.

How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary.

P. Morice, C. Uzan, S. Gouy, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary.

P. Morice, C. Uzan, S. Gouy, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Secondary Surgery in Patients With Serous Low Malignant Potential Ovarian Tumors With Peritoneal Implants

P. Morice, C. Uzan, S. Gouy, 2009, International Journal of Gynecologic Cancer.

Prognostic factors for patients with advanced stage serous borderline tumours of the ovary.

C. Haie-meder, D. Atallah, P. Morice, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma.

C. Haie-meder, P. Morice, P. Duvillard, 1999, Gynecologic oncology.

Results of conservative treatment in epithelial ovarian carcinoma

C. Haie-meder, R. de Crevoisier, P. Morice, 2001, Cancer.

Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.

C. Haie-meder, C. Genestie, S. Culine, 2016, Gynecologic oncology.

Long-term evaluation of Ifosfamide-related nephrotoxicity in children.

G. Leverger, D. Orbach, P. Niaudet, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.

D. Orbach, M. Terrier-Lacombe, O. Oberlin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop.

M. Stevens, M. Carli, O. Oberlin, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.

C. Balleyguier, A. Leary, J. Droz, 2014, European journal of cancer.

Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis.

P. Voûte, C. Rodary, J. Otten, 1988, Medical and pediatric oncology.

Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

James R. Anderson, M. Stevens, M. Carli, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

c‐crbB2 gene amplification and protein expression in ovarian epithelial tumors: Evaluation of their respective prognostic significance by multivariate analysis

J. Bernaudin, G. Riou, A. Fajac, 1995, International journal of cancer.

Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology.

O. Delattre, M. Stevens, O. Oberlin, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.

C. Haie-meder, P. Rouanet, D. Cowen, 2012, The oncologist.

Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.

C. Haie-meder, P. Morice, C. Uzan, 2010, The oncologist.

Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors

P. Morice, P. Kerbrat, P. Duvillard, 2007, International Journal of Gynecologic Cancer.

Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study.

D. Atallah, P. Morice, C. Pomel, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.

P. Voûte, A. Barrett, J. Habrand, 1998, European journal of cancer.

Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.

R. Potter, M. Carli, J. Zucker, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).

J. Blay, F. Collin, S. Piperno-Neumann, 2012, The oncologist.

Phase I clinical trial combining imatinib mesylate and IL-2

L. Zitvogel, A. Eggermont, N. Chaput, 2013, Oncoimmunology.

Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups

A. Ferrari, D. Orbach, M. V. van Noesel, 2013, Pediatric blood & cancer.

Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.

M. Stevens, M. Gaze, M. Ben Arush, 2012, European journal of cancer.

Prognostic factors for survival in patients with brain metastases from renal cell carcinoma

S. Culine, J. Droz, B. Escudier, 1998, Cancer.

Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.

G. Vujanić, J. Delemarre, B. Sandstedt, 2000, Medical and pediatric oncology.

Preoperative care of infants with nephroblastoma the international society of pediatric oncology 6 experience

P. Voûte, M. Carli, M. Coppes, 1992, Cancer.

Final results of a FNCLCC French Sarcoma Group multicenter randomized phase II study of gemcitabine (G) versus gemcitabine and docetaxel (G+D) in patients with metastatic or relapsed leiomyosarcoma (LMS).

F. Collin, S. Piperno-Neumann, N. Penel, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synovial sarcoma in children and adolescents: a critical reappraisal of staging investigations in relation to the rate of metastatic involvement at diagnosis.

M. Stevens, A. Ferrari, C. Morosi, 2012, European journal of cancer.

Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: Experience of the International Society of pediatric oncology, malignant mesenchymal tumors (SIOP‐MMT) Working Group

M. Stevens, A. Kelsey, D. Orbach, 2011, Pediatric blood & cancer.

Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups.

L. Mariani, M. Stevens, R. Miceli, 2011, European journal of cancer.

Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.

M. Stevens, O. Oberlin, R. Spicer, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.

H. B. Marsden, M. Stevens, H. Marsden, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Non-Metastatic Rhabdomyosarcomas in Childhood and Adolescence. Results of the Second Study of the International Society of Paediatric Oncology: MMT84

P. Walsh, P. Voûte, A. Barrett, 1999 .

Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy.

M. Stevens, J. Merks, J. Chisholm, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rhabdomyosarcoma in infants under one year of age: experience of the Institut Gustave-Roussy.

J. Caillaud, J. Lemerle, F. Flamant, 1989, Medical and pediatric oncology.

Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma

H. Brisse, C. Baunin, D. Cupissol, 2013, Cancer Chemotherapy and Pharmacology.

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients

L. Zitvogel, A. Eggermont, N. Chaput, 2013, Oncoimmunology.

Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups

K. Pritchard-Jones, C. Patte, P. Grundy, 2008, Pediatric blood & cancer.

UvA-DARE ( Digital Academic Repository ) Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1 , 2 , 5 , and 6

S. Guzzinati, M. Carli, M. Tournade, 1997 .

UvA-DARE ( Digital Academic Repository ) Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1 , 2 , 5 , and 6

L. Simonato, S. Guzzinati, M. Carli, 1997 .

Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: Results from International Society of Paediatric Oncology (SIOP) studies: Malignant mesenchymal tumour (MMT) 84, 89 and 95

C. Haie-meder, A. Kelsey, J. Merks, 2014, Pediatric blood & cancer.

Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma.

C. Haie-meder, V. Lazar, C. Balleyguier, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Nutritional Risk Factors in Planned Oncologic Surgery: What Clinical and Biological Parameters Should Be Routinely Used?

P. Bachmann, M. Vasson, G. Nitenberg, 2009, World Journal of Surgery.

Accuracy of diffusion-weighted echo-planar MR imaging and ADC mapping in the evaluation of residual cervical carcinoma after radiation therapy.

Cyrus Chargari, F. Bidault, C. Balleyguier, 2011, Gynecologic oncology.

Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.

C. Haie-meder, S. Culine, P. Morice, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer.

D. Atallah, P. Morice, C. Pomel, 2003, Journal of the American College of Surgeons.

Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registry.

C. Genestie, A. Dunant, E. Lanoy, 2020, Gynecologic oncology.

Prognostic factors in metastatic disease.

J. Droz, A. Kramar, A. Rey, 1992, Seminars in oncology.

[Survival and prognostic factors after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer].

C. Haie-meder, P. Morice, C. Uzan, 2011, Gynecologie, obstetrique & fertilite.

[Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure].

C. Haie-meder, D. Atallah, P. Morice, 2003, Gynecologie, obstetrique & fertilite.

Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone

C. Haie-meder, P. Morice, P. Kerbrat, 2004, International Journal of Gynecologic Cancer.

Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.

P. Terrier, T. Philip, O. Oberlin, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups

James R. Anderson, D. Hawkins, M. Carli, 2015, Pediatric blood & cancer.

Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease.

M. Stevens, D. Orbach, P. Thiesse, 2008, European journal of cancer.

Prognostic factors in non-seminomatous germ cell tumours of the testis. Experience at the Institut Gustave-Roussy.

S. Culine, J. Droz, A. Kramar, 1993, European urology.

MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy.

C. Haie-meder, I. Dumas, N. Magné, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery.

Christine Haie-Meder, Isabelle Dumas, C. Haie-meder, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Should Pelvic and Para-aortic Lymphadenectomy Be Different Depending on Histological Subtype in Epithelial Ovarian Cancer?

P. Morice, C. Uzan, S. Gouy, 2007, Annals of Surgical Oncology.

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin in localized uterine sarcomas: Results from 81 randomized patients.

C. Haie-meder, B. Weber, I. Ray-Coquard, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Postoperative morbidity after completion surgery following homogeneous chemoradiation therapy in locally advanced cervical cancer].

C. Haie-meder, P. Morice, C. Uzan, 2010, Journal de gynecologie, obstetrique et biologie de la reproduction.

Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome.

A. Gerbaulet, A. Rey, T. Girinsky, 1993, International journal of radiation oncology, biology, physics.

Treatment of nonmetastatic cranial parameningeal rhabdomyosarcoma in children younger than 3 years old: results from international society of pediatric oncology studies MMT 89 and 95.

M. Stevens, O. Oberlin, A. Defachelles, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.